Z 2345 Z 2345 (Procainamide 250 mg)
This pill with imprint "Z 2345 Z 2345" is Yellow, Capsule-shape and has been identified as Procainamide hydrochloride 250 mg. It is supplied by Teva Pharmaceuticals USA.
Procainamide is used in the treatment of myotonia congenita; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Procainamide 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about procainamide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: group I antiarrhythmics
- Procainamide capsules
- Procainamide controlled-release
- Procainamide injection
- Procainamide Intravenous (Advanced Reading)
Related treatment guides
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.